2,2,6,6-Tetrafluor-4-tert-butyl-morpholin | 65472-12-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2,2,6,6-Tetrafluor-4-tert-butyl-morpholin
• 英文别名: 4-tert-butyl-2,2,6,6-tetrafluoro-morpholine；4-Tert-butyl-2,2,6,6-tetrafluoromorpholine
• CAS: 65472-12-0
• 化学式: C₈H₁₃F₄NO
• 分子量: 215.191
• InChiKey: GATXBZXMDCVYIG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  1-(1,1-二氟-2-碘乙氧基)-1,1-二氟-2-碘乙烷 、 叔丁胺 反应 96.0h， 生成 2,2,6,6-Tetrafluor-4-tert-butyl-morpholin
  参考文献：
  名称：

  Kolinski,R.A. et al., Roczniki Chemii, 1977, vol. 51, p. 1365 - 1375

  摘要：

  DOI：

文献信息

• 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME
  申请人：Frequency Therapeutics, Inc.

  公开号：US20180214458A1

  公开（公告）日：2018-08-02

  The present invention relates to 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.

  本发明涉及1,5-二氢-2H-吡咯-2-酮化合物及其使用方法，用于诱导干/祖细胞支持细胞的自我更新，包括诱导干/祖细胞增殖同时保持子细胞中分化为组织细胞的能力。
• 1,2-DIHYDRO-3H-PYRAZOL-3-ONE COMPOUNDS AND METHODS OF USING SAME
  申请人：Frequency Therapeutics, Inc.

  公开号：US20200316089A1

  公开（公告）日：2020-10-08

  The present disclosure relates to 1,2-dihydro-3H-pyrazol-3-one compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.

  本公开涉及1,2-二氢-3H-吡唑-3-酮化合物及其使用方法，用于诱导干/祖细胞支持细胞的自我更新，包括诱导干/祖细胞增殖，同时维持子细胞中分化成组织细胞的能力。
• Potassium channel modulators
  申请人：Cadent Therapeutics, Inc.

  公开号：US10774064B2

  公开（公告）日：2020-09-15

  Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

  本发明提供了式 (I) 的新型化合物：及其药学上可接受的盐类，它们可用于治疗各种可受钾通道调节影响的疾病、失调或病症。还提供了包含式（I）新型化合物及其药学上可接受的盐的药物组合物，以及将其用于治疗一种或多种与钾通道相关的疾病、失调或病症的方法。
• 1H-pyrrole-2,5-dione compounds and methods of using same
  申请人：Frequency Therapeutics, Inc.

  公开号：US11066419B2

  公开（公告）日：2021-07-20

  The present invention relates to 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.

  本发明涉及 1H-吡咯-2,5-二酮化合物和使用它们诱导干/祖支持细胞自我更新的方法，包括诱导干/祖细胞增殖，同时保持子细胞分化成组织细胞的能力。
• POTASSIUM CHANNEL MODULATORS
  申请人：Cadent Therapeutics, Inc.

  公开号：US20190218200A1

  公开（公告）日：2019-07-18

  Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.